
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway
Yitian Dai, Yuping Liu, Jingyi Li, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13906-13918
Open Access | Times Cited: 48
Yitian Dai, Yuping Liu, Jingyi Li, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13906-13918
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer
Fei Li, Henghui Zhang, Yu‐An Huang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101059-101059
Closed Access | Times Cited: 56
Fei Li, Henghui Zhang, Yu‐An Huang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101059-101059
Closed Access | Times Cited: 56
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 49
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 49
Traditional Chinese Medicine for Cancer Treatment
Yangli Liu, Fang Cheng, Jiaojiao Luo, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 03, pp. 583-604
Closed Access | Times Cited: 16
Yangli Liu, Fang Cheng, Jiaojiao Luo, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 03, pp. 583-604
Closed Access | Times Cited: 16
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation
Xinyu Qian, Lin Zhu, Mengzhen Xu, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110588-110588
Closed Access | Times Cited: 24
Xinyu Qian, Lin Zhu, Mengzhen Xu, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110588-110588
Closed Access | Times Cited: 24
Reprogramming of glucose metabolism: The hallmark of malignant transformation and target for advanced diagnostics and treatments
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 10
Qing Tang, Siqi Wu, Baiming Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117257-117257
Open Access | Times Cited: 10
Advancing functional foods: a systematic analysis of plant-derived exosome-like nanoparticles and their health-promoting properties
Ke Che, Cong Wang, Hao Chen
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
Ke Che, Cong Wang, Hao Chen
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
Targeting glycolysis in non-small cell lung cancer: Promises and challenges
Jiaqi Xu, Yanli Fu, Jing Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Jiaqi Xu, Yanli Fu, Jing Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
A new strategy for osteoarthritis therapy: Inhibition of glycolysis
Chunmei Tan, Lanqing Li, Juanjuan Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Chunmei Tan, Lanqing Li, Juanjuan Han, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
Tumor energy metabolism: implications for therapeutic targets
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 7
Treating cancer through modulating exosomal protein loading and function: The prospects of natural products and traditional Chinese medicine
Lulu Meng, Chao Zhang, Pei Yu
Pharmacological Research (2024) Vol. 203, pp. 107179-107179
Open Access | Times Cited: 6
Lulu Meng, Chao Zhang, Pei Yu
Pharmacological Research (2024) Vol. 203, pp. 107179-107179
Open Access | Times Cited: 6
Nano-constructs targeting the primary cellular energy source of cancer cells for modulating tumor progression
Krishna Yadav, Deependra Singh, Manju Rawat Singh, et al.
OpenNano (2022) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 26
Krishna Yadav, Deependra Singh, Manju Rawat Singh, et al.
OpenNano (2022) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 26
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 16
Dexin Shen, Zhao Deng, Wei Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 16
Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation
Min Wang, Yangyan Sun, Rui Gu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Min Wang, Yangyan Sun, Rui Gu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12
Fahad Alsaikhan
Environmental Research (2023) Vol. 237, pp. 116951-116951
Closed Access | Times Cited: 12
Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques
Dabao He, Hengfeng Tang, Yang Xiaoling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Dabao He, Hengfeng Tang, Yang Xiaoling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Synergistic Effect of Ribitol and Shikonin Promotes Apoptosis in Breast Cancer Cells
Ravi Doddapaneni, Jason D. Tucker, Pei Lu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2661-2661
Open Access
Ravi Doddapaneni, Jason D. Tucker, Pei Lu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2661-2661
Open Access
Shikonin a potent phytotherapeutic: a comprehensive review on metabolic reprogramming to overcome drug resistance in cancer
Stuti Biswal, Sanjeeb Kumar Sahoo, Bijesh K. Biswal
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Stuti Biswal, Sanjeeb Kumar Sahoo, Bijesh K. Biswal
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Targeting Redox Signaling Through Exosomal MicroRNA: Insights into Tumor Microenvironment and Precision Oncology
Moon Nyeo Park, Myoungchan Kim, Soojin Lee, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 501-501
Open Access
Moon Nyeo Park, Myoungchan Kim, Soojin Lee, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 501-501
Open Access
Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
Man Yao, Shufang Liang, Binbin Cheng
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Man Yao, Shufang Liang, Binbin Cheng
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Alpha-hederin reprograms multi-miRNAs activity and overcome small extracellular vesicles-mediated paclitaxel resistance in NSCLC
Yuzhen Chang, Xinyu Gao, Yuchen Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Yuzhen Chang, Xinyu Gao, Yuchen Jiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Juglone induces ferroptosis in glioblastoma cells by inhibiting the Nrf2-GPX4 axis through the phosphorylation of p38MAPK
Fangzhou Guo, Guoyuan Ling, Jianting Qiu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Fangzhou Guo, Guoyuan Ling, Jianting Qiu, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Aerobic glycolysis of vascular endothelial cells: a novel perspective in cancer therapy
Shenhao Xu, Jiahao Liao, Bing Liu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 3
Shenhao Xu, Jiahao Liao, Bing Liu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 3
Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy
Yuting Cui, Chuang Li, Sang Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Yuting Cui, Chuang Li, Sang Feng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Shikonin-Loaded Hollow Fe-MOF Nanoparticles for Enhanced Microwave Thermal Therapy
Lufeng Chen, Dongming Zhao, Xiangling Ren, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 9, pp. 5405-5417
Open Access | Times Cited: 8
Lufeng Chen, Dongming Zhao, Xiangling Ren, et al.
ACS Biomaterials Science & Engineering (2023) Vol. 9, Iss. 9, pp. 5405-5417
Open Access | Times Cited: 8